NEW YORK (360Dx) – Clinicians looking for a noninvasive diagnostic test that aids in detecting non-small cell lung cancer DNA could have a high-performance saliva-based laboratory-developed test within a year, according to its developers at the University of California, Los Angeles.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.